Plasma fibroblast growth factor-21 and abdominal obesity

Journal of Sichuan University (Medical Science)

Volumn 41, Issue 3, 2010, Pages

  Zhang, Mei ^a   Xiong, Zhong Yun ^a   Zeng, Li ^a   Wang, You Juan ^a   Huang, Ming Jie ^a   An, Zhen Mei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Abdominal obesity; Fibroblast growth factor 21(FGF 21)

Indexed keywords

EID: 77953095673     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Coskun T, Bina HA, Schneider MA. et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology. 2008;149 (12):6018-6027.
2. Katz At Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in human. J Clin Endocrinol Metab, 2000;83 (7):2402-2410.
3. Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of bodyfatness: age and sex specific predition for mulas. Br J Nutr, 1991;65(2): 105-114.
4. Nishimura T, Nakatake Y, Konishi M, et al. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta, 2000;1492(1):203-206.
5. Badman MK, Pissios P, Kennedy AR, et al. Hepatic fibroblast growth factor-21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab, 2007;5(6):426-437.
6. Zhang X, Yeung DC, Karpisek M, et al. Serum FGF-21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes, 2008;57 (5): 1246-1253.
7. Xu J, Lloyd DJ, Hale C, et al. Fibroblast growth factor-21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes, 2009;58(1):250-259.
8. Chen WW, Li L, Yang GY, et al. Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes, 2008;116(1): 65-68.
9. Qälman C, Lundäsen T, Kharitonenkov A, et al. The circulating metabolic regulator FGF-21 is induced by prolonged fasting and PR AR alpha activcation in man. Cell Metab, 2008;8 (2): 169-174.
10. Inagaki T, Dutchak P, Zhao G, et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor-21. Cell Metab, 2007;5(6):415-425.
11. Arner P, Pettersson A, Mitchell PJ, et al. FGF-21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity. FEBS Lett, 2008;582(12):1725-1730.
12. Li H, Bao Y, Xu A, et al. Serum fibroblast growth factor-21 is associated with adverse lipid profiles and {gamma}-glutamyltransferase but not insulin sensitivity in Chinese subjects. J Clin Endocrinol Metab, 2009;94(6):2151-2156.